Emerging Therapies for Advanced Cholangiocarcinoma: An Updated Literature Review
Cholangiocarcinoma is a group of malignancies with poor prognosis. Treatments for the management of advanced-stage cholangiocarcinoma are limited, and the 5-year survival rate is estimated to be approximately 5–15%, considering all tumor stages. There is a significant unmet need for effective new tr...
Guardado en:
Autores principales: | Anthony Vignone, Francesca Biancaniello, Marco Casadio, Ludovica Pesci, Vincenzo Cardinale, Lorenzo Ridola, Domenico Alvaro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/82767877420544568ea0e262ab6c2d4e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
por: Ashish Manne, et al.
Publicado: (2021) -
Vascular Resection in Perihilar Cholangiocarcinoma
por: Alejandro Serrablo, et al.
Publicado: (2021) -
MANAGING SYMPTOM CLUSTER AMONG PATIENTS WITH CHOLANGIOCARCINOMA: A CALL FOR NURSES
por: Surachai Maninet, et al.
Publicado: (2018) -
Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
por: Serifis N, et al.
Publicado: (2021) -
Complete laparoscopic radical resection of hilar cholangiocarcinoma: technical aspects and long-term results from a single center
por: Jingdong Li, et al.
Publicado: (2020)